INVO Bioscience Inc (INVO)
0.87
-0.05
(-5.94%)
USD |
NASDAQ |
May 06, 16:00
0.87
0.00 (0.00%)
After-Hours: 18:34
INVO Bioscience Total Liabilities (Quarterly): 20.00M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.00M |
| September 30, 2023 | 19.10M |
| June 30, 2023 | 8.344M |
| March 31, 2023 | 6.063M |
| December 31, 2022 | 5.081M |
| September 30, 2022 | 3.391M |
| June 30, 2022 | 3.068M |
| March 31, 2022 | 2.930M |
| December 31, 2021 | 3.156M |
| September 30, 2021 | 5.789M |
| June 30, 2021 | 5.573M |
| March 31, 2021 | 4.592M |
| December 31, 2020 | 5.204M |
| September 30, 2020 | 5.591M |
| June 30, 2020 | 5.904M |
| March 31, 2020 | 5.393M |
| December 31, 2019 | 5.509M |
| Date | Value |
|---|---|
| September 30, 2019 | 6.325M |
| June 30, 2019 | 6.555M |
| March 31, 2019 | 6.606M |
| December 31, 2018 | 3.502M |
| September 30, 2018 | 5.348M |
| June 30, 2018 | 5.277M |
| March 31, 2018 | 5.216M |
| December 31, 2017 | 5.258M |
| September 30, 2017 | 5.080M |
| June 30, 2017 | 4.986M |
| March 31, 2017 | 4.910M |
| December 31, 2016 | 4.904M |
| September 30, 2016 | 4.731M |
| June 30, 2016 | 4.585M |
| March 31, 2016 | 4.488M |
| December 31, 2015 | 4.337M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.930M
Minimum
Mar 2022
20.00M
Maximum
Dec 2023
6.714M
Average
5.573M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Abbott Laboratories | 34.39B |
| Perspective Therapeutics Inc | 22.71M |
| Xtant Medical Holdings Inc | 41.26M |
| Asensus Surgical Inc | 25.67M |
| Catheter Precision Inc | 9.544M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.89M |
| Shareholders Equity (Quarterly) | 0.8928M |
| Debt to Equity Ratio | 3.096 |
| Current Ratio | 0.1533 |
| Net Debt Paydown Yield | -16.43% |